A

Aerovate Therapeutics, Inc.

33 employees

Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Life Science

Date founded

2018

Funding rounds raised

Total raised

$73M

from 5 investors over 5 rounds

A

Aerovate Therapeutics, Inc. raised $73M on August 6, 2020

Investors: Sofinnova Ventures, Russia technology fund, Atlas Venture, Surveyor Capital and Osage University Partners (OUP)

A

Aerovate Therapeutics, Inc. raised undisclosed on January 1, 2020

Investors: RA Capital Management, L.P.

FAQ